RAFAEL HOLDINGS, INC. Debt Conversion, Original Debt, Interest Rate of Debt
RAFAEL HOLDINGS, INC. (RFL) reported Debt Conversion, Original Debt, Interest Rate of Debt of 3.50% for the 12-month period ending 2024-07-31, per its 10-K/A filed 2024-12-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtInterestRateOfDebt · last filed 2024-12-20
- RAFAEL HOLDINGS, INC. debt conversion, original debt, interest rate of debt for fiscal 2024 was 3.50%.
| Period end | Debt Conversion, Original Debt, Interest Rate of Debt 9 month | Debt Conversion, Original Debt, Interest Rate of Debt 12 month |
|---|---|---|
| 2024-07-31 | 3.50% 10-K/A · filed 2024-12-20 | |
| 2024-04-30 | 3.50% 10-Q · filed 2024-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |